195 related articles for article (PubMed ID: 12085228)
1. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
Clark PA; Llanos S; Peters G
Oncogene; 2002 Jul; 21(29):4498-507. PubMed ID: 12085228
[TBL] [Abstract][Full Text] [Related]
2. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
3. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.
Xirodimas DP; Chisholm J; Desterro JM; Lane DP; Hay RT
FEBS Lett; 2002 Sep; 528(1-3):207-11. PubMed ID: 12297306
[TBL] [Abstract][Full Text] [Related]
4. Defining the molecular basis of Arf and Hdm2 interactions.
Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
[TBL] [Abstract][Full Text] [Related]
5. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
Rizos H; Darmanian AP; Mann GJ; Kefford RF
Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
[TBL] [Abstract][Full Text] [Related]
6. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
[TBL] [Abstract][Full Text] [Related]
7. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.
Zhang Y; Xiong Y; Yarbrough WG
Cell; 1998 Mar; 92(6):725-34. PubMed ID: 9529249
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
9. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
Yin Y; Stephen CW; Luciani MG; Fåhraeus R
Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
Llanos S; Clark PA; Rowe J; Peters G
Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
[TBL] [Abstract][Full Text] [Related]
11. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
[TBL] [Abstract][Full Text] [Related]
12. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
[TBL] [Abstract][Full Text] [Related]
13. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
14. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
Khan S; Guevara C; Fujii G; Parry D
Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
[TBL] [Abstract][Full Text] [Related]
15. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
[TBL] [Abstract][Full Text] [Related]
16. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG
Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets.
Ghimenti C; Fiano V; Chiadò-Piat L; Chiò A; Cavalla P; Schiffer D
J Neurooncol; 2003 Jan; 61(2):95-102. PubMed ID: 12622447
[TBL] [Abstract][Full Text] [Related]
19. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
[TBL] [Abstract][Full Text] [Related]
20. Hypophosphorylation of Mdm2 augments p53 stability.
Blattner C; Hay T; Meek DW; Lane DP
Mol Cell Biol; 2002 Sep; 22(17):6170-82. PubMed ID: 12167711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]